From January 1, 2023 to February 2, 2023, the company has repurchased 22,972 shares, representing 0.007245% for CNY 1.67 million. With this, the company has completed the repurchase of 1,459,586 shares, representing 0.46% for CNY 99.69 million under the buyback announced on February 7, 2022.
Qingdao Haier Biomedical Co.,Ltd
Equities
688139
CNE100003P25
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33.65 CNY | +2.59% | +7.06% | -16.95% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.95% | 1.47B | |
+3.31% | 209B | |
+2.05% | 175B | |
+9.36% | 131B | |
+17.66% | 99.98B | |
-1.67% | 61.12B | |
+14.05% | 52.34B | |
-4.15% | 46.5B | |
-3.68% | 39.24B | |
+9.04% | 38.47B |
- Stock Market
- Equities
- 688139 Stock
- News Qingdao Haier Biomedical Co.,Ltd
- Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.